Market Cap 9.72M
Revenue (ttm) 0.00
Net Income (ttm) -30.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 181,900
Avg Vol 62,082
Day's Range N/A - N/A
Shares Out 4.54M
Stochastic %K 41%
Beta 0.03
Analysts Strong Sell
Price Target $3.50

Company Profile

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product ca...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 600 6438
Website: in8bio.com
Address:
350 5th Avenue, Suite 5330, New York, United States
aw20
aw20 Oct. 27 at 1:47 PM
$INAB grabbed some at 2.05 👀
0 · Reply
Neegud
Neegud Oct. 27 at 12:40 PM
$INAB Come to $CLRB low float with FDA approved drug today.
0 · Reply
Stmkr
Stmkr Oct. 27 at 12:38 PM
$INAB Interesting data. B cell depletion with less systemic immune activation
0 · Reply
Its_Never_Too_Late
Its_Never_Too_Late Oct. 27 at 12:24 PM
$INAB Not only is Wall Street underappreciating $INAB oncology pipeline, most investors are not even aware of their superior, in-hoise developed, autoimmune pipeline. My guess is that larger biotechnology/pharmaceutical companies are very aware of whats going on at IN8bio. Wall Street will likely wake up to the stock after a headline (partnership) spikes the price per share to 5-10X from the current levels. I've seen this movoe before. An example was $FATE. It was dead money for a long time, then when the street woke up to the pipeline stock ripped from a few bucks per share to >$100 per share in 2021. There are too many others to list.
0 · Reply
taneraydar
taneraydar Oct. 27 at 12:22 PM
$INAB 17k in
1 · Reply
Neegud
Neegud Oct. 27 at 12:16 PM
$INAB added at 2.1. FDA news.
0 · Reply
MrTicker
MrTicker Oct. 27 at 12:04 PM
$INAB IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications GLOBENEWSWIRE 7:00 AM ET 10/27/2025
0 · Reply
TKKKKT
TKKKKT Oct. 27 at 11:14 AM
$INAB on watch…
1 · Reply
GarbageHands
GarbageHands Oct. 24 at 4:21 PM
$INAB it’s brewing up ready for a squeeze After hours
0 · Reply
unearthedmosquito
unearthedmosquito Oct. 24 at 12:29 PM
$INAB Adding 2.10s.
0 · Reply
Latest News on INAB
IN8bio to Present at Upcoming Investor Conferences

Feb 26, 2024, 8:00 AM EST - 1 year ago

IN8bio to Present at Upcoming Investor Conferences


IN8bio Appoints Dr. Corinne Epperly to Board of Directors

Dec 7, 2023, 8:00 AM EST - 2 years ago

IN8bio Appoints Dr. Corinne Epperly to Board of Directors


aw20
aw20 Oct. 27 at 1:47 PM
$INAB grabbed some at 2.05 👀
0 · Reply
Neegud
Neegud Oct. 27 at 12:40 PM
$INAB Come to $CLRB low float with FDA approved drug today.
0 · Reply
Stmkr
Stmkr Oct. 27 at 12:38 PM
$INAB Interesting data. B cell depletion with less systemic immune activation
0 · Reply
Its_Never_Too_Late
Its_Never_Too_Late Oct. 27 at 12:24 PM
$INAB Not only is Wall Street underappreciating $INAB oncology pipeline, most investors are not even aware of their superior, in-hoise developed, autoimmune pipeline. My guess is that larger biotechnology/pharmaceutical companies are very aware of whats going on at IN8bio. Wall Street will likely wake up to the stock after a headline (partnership) spikes the price per share to 5-10X from the current levels. I've seen this movoe before. An example was $FATE. It was dead money for a long time, then when the street woke up to the pipeline stock ripped from a few bucks per share to >$100 per share in 2021. There are too many others to list.
0 · Reply
taneraydar
taneraydar Oct. 27 at 12:22 PM
$INAB 17k in
1 · Reply
Neegud
Neegud Oct. 27 at 12:16 PM
$INAB added at 2.1. FDA news.
0 · Reply
MrTicker
MrTicker Oct. 27 at 12:04 PM
$INAB IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications GLOBENEWSWIRE 7:00 AM ET 10/27/2025
0 · Reply
TKKKKT
TKKKKT Oct. 27 at 11:14 AM
$INAB on watch…
1 · Reply
GarbageHands
GarbageHands Oct. 24 at 4:21 PM
$INAB it’s brewing up ready for a squeeze After hours
0 · Reply
unearthedmosquito
unearthedmosquito Oct. 24 at 12:29 PM
$INAB Adding 2.10s.
0 · Reply
GarbageHands
GarbageHands Oct. 23 at 12:21 AM
$INAB buck in boys tml is showing a huge trend very soon
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Oct. 16 at 1:19 AM
0 · Reply
TheSuper
TheSuper Oct. 14 at 1:20 PM
$INAB im not in this stock. Its on my watchlist though. I had a vivid dream this exploded. Will ha e to circle back around on the potential here.
0 · Reply
MilsLearning
MilsLearning Oct. 13 at 9:02 AM
$INAB "L"ets "F" "S"horts 🔥🩳🔥✅🔥🩳✅🔜🔥🩳🖕🕖 Ever get bullied??? Trading stocks?? Me too!!! Get the bullies out of the schools 🏫 The IPO Foreign Meme movement ***LFS***
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:43 PM
Keep a close watch on CMCT! $INAB $OGEN $AGMH $LYEL 1
0 · Reply
justiceforb_85
justiceforb_85 Oct. 9 at 2:35 AM
$INAB are we receiving an update on data for INB-100 later this year, or just an update on enrollment status?
0 · Reply
BioPharm_Swinger
BioPharm_Swinger Oct. 7 at 5:33 PM
$INAB Can fill some gaps at $4! Data due any day now.
0 · Reply
_www_larval_com_
_www_larval_com_ Oct. 7 at 1:47 PM
$INAB has dropped -10% lower to -1% (~37Kv) a moment ago, follow for more volatility.
0 · Reply
Schizoo
Schizoo Oct. 7 at 1:17 PM
0 · Reply
unearthedmosquito
unearthedmosquito Oct. 7 at 12:36 PM
$INAB whats that movement about
0 · Reply